EUVIMEDOntdek EUVIMED
BeobachtungsstudieOpen access · CC BY-NC 4.0

Burden of vaso‐occlusive crisis, its management and impact on quality of life of Indian sickle cell disease patients

Tulika Seth, Shashank Udupi, Suman Jain iD, Seema Bhatwadekar, Nandakumar Menon, Rabindra Kumar Jena, Ravindra Kumar iD, Shomik Ray iD, Bharat Parmar, Anil Kumar Goel, Ashvin Vasava, Anupam Dutta and 8 more

British Journal of Haematology · 2025-01 · 206 (1) · 296-309

DOI: 10.1111/bjh.19829 ↗

At a glance

Beobachtungsstudie in British Journal of Haematology, published online on 2024-10-28. Written by Tulika Seth and 19 co-authors. Institution: Department of Hematology, All-India Institute of Medical Sciences, New Delhi, Delhi, India. Major MEDLINE topics: Anemia, Sickle Cell, Quality of Life. Cited 13 times so far (Crossref); 46 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Novartis Healthcare Private Limited.

SamenvattingSubjectsBibliografische gegevensCiteRelated studies

Abstract (original language)

Sickle cell disease (SCD) with vaso‐occlusive pain crisis (VOC) significantly impacts patient well‐being and often results in extensive healthcare resource utilization. This study assessed the VOC burden, its management and its impact on patients' quality of life (QoL). A cross‐sectional observational study was conducted between November 2021 and June 2022, including 1000 SCD patients from high‐prevalence states in India. Data on demographics, clinical characteristics, VOC severity, management and QoL were collected. The study revealed that 33.5% of patients reported at least one VOC episode during the study period. In the year prior to their enrolment, 836 (83.60%) patients reported at least one VOC episode, with an equal proportion of 407/487 (83.6%) adults and 429/513 (83.6%) paediatric patients, reducing their QoL across all domains compared to patients without VOC. Of these, 469/1000 patients (46.9%) experienced ≥3 VOC episodes. Additionally, 764/1000 (76.40%) patients managed their VOCs at healthcare facilities, with 501/1000 (50.1%) requiring inpatient admissions. Further, 71.80% of patients received Hydroxyurea (HU) therapy. The study depicts the severity of the Arab–Indian haplotype in Indian SCD patients visiting healthcare settings based on high VOC burden. This highlights the urgent need for better management strategies and resource allocation for these patients.

Subjects

MeSH terms (MEDLINE)

Anemia, Sickle CellQuality of LifeHumansIndiaFemaleMaleAdultAdolescentCross-Sectional StudiesChildYoung AdultMiddle AgedChild, PreschoolCost of Illness

Author keywords

healthcare utilizationquality of lifesickle cell diseasevaso‐occlusive crisis

Authors and institutions

  • Department of Hematology, All-India Institute of Medical Sciences, New Delhi, Delhi, India.
  • Department of Oncology Medical Affairs, Novartis Healthcare Private Limited, Mumbai, Maharashtra, India.
  • Thalassemia and Sickle Cell Society, Hyderabad, Telangana, India.
  • Haemato Oncology Care Centre, Vadodara, Gujarat, India.
  • ASHWINI Gudalur Adivasi Hospital, Gudalur, Tamil Nadu, India.
  • Srirama Chandra Bhanj Medical College & Hospital, Cuttack, Odisha, India.

ORCID profiles: Suman Jain, Ravindra Kumar, Shomik Ray, Dipty Jain

Funding

  • Novartis Healthcare Private Limited

Cite

APA

Seth, T., Udupi, S., Jain, S., Bhatwadekar, S., Menon, N., Jena, R. K., Kumar, R., Ray, S., Parmar, B., Goel, A. K., Vasava, A., Dutta, A., Samal, P., Ballikar, R., Bhat, D., Dolai, T. K., Bhattacharyya, J., Shetty, D., Mistry, M., & Jain, D. (2025). Burden of vaso‐occlusive crisis, its management and impact on quality of life of Indian sickle cell disease patients. British Journal of Haematology, 206(1), 296-309. https://doi.org/10.1111/bjh.19829

Vancouver

Seth T, Udupi S, Jain S, Bhatwadekar S, Menon N, Jena RK, et al. Burden of vaso‐occlusive crisis, its management and impact on quality of life of Indian sickle cell disease patients. British Journal of Haematology. 2025;206(1):296-309. doi:10.1111/bjh.19829

BibTeX
@article{Seth2025,
  author = {Seth, Tulika and Udupi, Shashank and Jain, Suman and Bhatwadekar, Seema and Menon, Nandakumar and Jena, Rabindra Kumar and Kumar, Ravindra and Ray, Shomik and Parmar, Bharat and Goel, Anil Kumar and Vasava, Ashvin and Dutta, Anupam and Samal, Priyanka and Ballikar, Riya and Bhat, Deepa and Dolai, Tuphan Kanti and Bhattacharyya, Jina and Shetty, Disha and Mistry, Manish and Jain, Dipty},
  title = {Burden of vaso‐occlusive crisis, its management and impact on quality of life of Indian sickle cell disease patients},
  journal = {British Journal of Haematology},
  year = {2025},
  volume = {206},
  number = {1},
  pages = {296--309},
  doi = {10.1111/bjh.19829}
}
Start for free →